Brookfield Corporation Class A Limited Voting Shares (BN)

Accounts Payable

$63.71B

Quarterly · Period ending: · USD

BN logo

BN Accounts Payable

Latest reported$63.71B
BN Quarterly Accounts Payable ($0.00 → $63.71B)
High-resolution chart · PNG

BN accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brookfield Corporation Class A Limited Voting Shares Accounts Payable — Quarterly (USD)
Period endingAccounts Payable (USD)
63,706,000,000
33,569,000,000
62,348,000,000
30,633,000,000
30,514,000,000
27,904,000,000
30,125,000,000
32,200,000,000
32,445,000,000
31,756,000,000
33,414,000,000
32,214,000,000
34,908,000,000
34,709,000,000
33,574,000,000
31,333,000,000
30,084,000,000
31,271,000,000
29,136,000,000
29,076,000,000
27,967,000,000
24,876,000,000
25,857,000,000
23,647,000,000
21,908,000,000
20,835,000,000
23,212,000,000
18,041,000,000
17,126,000,000
14,763,000,000
14,337,000,000
13,956,000,000
11,785,000,000
11,960,000,000
11,148,000,000
10,899,000,000
9,968,000,000
7,708,000,000
7,721,000,000
7,876,000,000
7,955,000,000
7,874,000,000
7,560,000,000
7,475,000,000
7,050,000,000
6,268,000,000
6,054,000,000
6,092,000,000
6,796,000,000
6,598,000,000
5,994,000,000
6,096,000,000
5,541,000,000
5,900,000,000
7,203,000,000
10,480,000,000
9,837,000,000
9,742,000,000
5,342,000,000
8,776,000,000
10,943,000,000
10,602,000,000
4,581,000,000
7,950,000,000
7,341,000,000
7,390,000,000
10,017,000,000
10,066,000,000
8,854,000,000
8,182,000,000
8,904,000,000
8,723,000,000
10,576,000,000
10,510,877,000
9,863,000,000
8,348,893,000
7,766,839,000
6,648,328,000
6,497,000,000
5,338,000,000
5,126,000,000
4,644,000,000
3,922,000,000
4,374,443,000
4,584,986,000
3,836,381,000
2,719,000,000
2,213,772,000
1,896,511,000
2,040,665,000
1,745,000,000
1,637,123,000
1,437,068,000
1,232,087,000
1,267,000,000
1,210,192,000
1,134,163,000
1,189,859,000
1,078,912,000
801,525,079
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.